Multi-agonists may engage multiple receptor systems; assay selection matters. Mechanism summaries should cite receptor binding and signaling data when available.
Clear policies reduce customer confusion and regulatory risk. Separate educational content from medical claims.
Different studies may use different dosing schedules and populations. Compare outcomes with consistent metrics where possible.
